Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 15, Pages 7800
Publisher
MDPI AG
Online
2021-07-21
DOI
10.3390/ijms22157800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab (pembro) vs placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase III KEYNOTE-240 study.
- (2021) Philippe Merle et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
- (2020) Erez N. Baruch et al. SCIENCE
- Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
- (2019) Rajbir Singh et al. Nature Communications
- Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
- (2019) Qisha Liu et al. Gut Pathogens
- Gut microbiota regulates lacteal integrity by inducing VEGF‐C in intestinal villus macrophages
- (2019) Sang Heon Suh et al. EMBO REPORTS
- Lactobacillus acidophilus and Bifidobacteria spp having antibacterial and antiviral effects on chronic HCV infection
- (2019) G. Allam Nanis et al. African Journal of Microbiology Research
- Biotransformation of Cranberry Proanthocyanidins to Probiotic Metabolites by Lactobacillus rhamnosus Enhances Their Anticancer Activity in HepG2 Cells In Vitro
- (2019) H. P. Vasantha Rupasinghe et al. Oxidative Medicine and Cellular Longevity
- Involvement of TLR4/ CXCL9/ PREX-2 Pathway in the Development of Hepatocellular Carcinoma (HCC) and The Promising Role of Early Administration of Lactobacillus Plantarum in Wistar Rats
- (2019) Asmaa M. Elshaer et al. TISSUE & CELL
- Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
- (2019) Sang Bong Ahn et al. Scientific Reports
- Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
- (2019) Yi Zheng et al. Journal for ImmunoTherapy of Cancer
- Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial β-Glucuronidases
- (2019) Samantha M. Ervin et al. ACS Chemical Biology
- LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
- (2019) T Yau et al. ANNALS OF ONCOLOGY
- Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma
- (2019) Yongbin Zeng et al. JOURNAL OF VIRAL HEPATITIS
- Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis
- (2018) Daniel So et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Recent developments with immunotherapy for hepatocellular carcinoma
- (2018) Oliver Waidmann EXPERT OPINION ON BIOLOGICAL THERAPY
- Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease
- (2018) Francesca Romana Ponziani et al. HEPATOLOGY
- Protective effects of selenium-glutathione-enriched probiotics on CCl 4 -induced liver fibrosis
- (2018) Yunhuan Liu et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
- (2018) Smruti Pushalkar et al. Cancer Discovery
- Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
- (2018) Florian Huemer et al. Oncotarget
- Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice
- (2018) Shoji Yamada et al. Oncotarget
- Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy
- (2018) Murphy L. Y. Wan et al. HEPATOBILIARY SURGERY AND NUTRITION
- The Microbiome in Cirrhosis and Its Complications
- (2018) Chathur Acharya et al. Clinical Gastroenterology and Hepatology
- Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
- (2018) Zhigang Ren et al. GUT
- Fecal microbiota transplantation: Review and update
- (2018) Jiunn-Wei Wang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors
- (2018) Jibran Ahmed et al. OncoImmunology
- LBA26Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)
- (2018) M J Pishvaian et al. ANNALS OF ONCOLOGY
- Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials
- (2018) S Sen et al. ANNALS OF ONCOLOGY
- Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer
- (2018) Vishal Singh et al. CELL
- Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis
- (2018) Jun Huang et al. Nature Microbiology
- Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
- (2017) Feng Shen et al. Hepatobiliary & Pancreatic Diseases International
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Gut microbiota modulation of chemotherapy efficacy and toxicity
- (2017) James L. Alexander et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Oral administration of probiotic Lactobacillus paraplantarum BGCG11 attenuates diabetes-induced liver and kidney damage in rats
- (2017) Mirjana Mihailović et al. Journal of Functional Foods
- Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE 2 -Mediated Suppression of Antitumor Immunity
- (2017) Tze Mun Loo et al. Cancer Discovery
- Probiotics, prebiotics and colorectal cancer prevention
- (2016) Padma Ambalam et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Investigating probiotic yoghurt to reduce an aflatoxin B1 biomarker among school children in eastern Kenya: Preliminary study
- (2016) Nicholas Nduti et al. INTERNATIONAL DAIRY JOURNAL
- Gut–liver immunity
- (2016) Palak J. Trivedi et al. JOURNAL OF HEPATOLOGY
- Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
- (2016) Jun Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease
- (2016) Peter Stärkel et al. SEMINARS IN LIVER DISEASE
- Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut
- (2016) Audrey Rivière et al. Frontiers in Microbiology
- Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
- (2016) Baohong Wang et al. Scientific Reports
- Effects of dietary inulin on bacterial growth, short-chain fatty acid production and hepatic lipid metabolism in gnotobiotic mice
- (2015) Karolin Weitkunat et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Dysbiosis of Intestinal Microbiota Associated With Inflammation Involved in the Progression of Acute Pancreatitis
- (2015) Chaochao Tan et al. PANCREAS
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease
- (2014) S. Nabavi et al. JOURNAL OF DAIRY SCIENCE
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma
- (2014) Dalvinder S Mandair et al. Expert Review of Gastroenterology & Hepatology
- Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus
- (2013) Do Kyung Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach
- (2013) Xiao Wei et al. BMC GASTROENTEROLOGY
- Therapeutic Potential of Fecal Microbiota Transplantation
- (2013) Loek P. Smits et al. GASTROENTEROLOGY
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
- (2013) Yukihiro Furusawa et al. NATURE
- Chemopreventive and Therapeutic Potential of Tea Polyphenols in Hepatocellular Cancer
- (2013) Altaf S. Darvesh et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation
- (2013) Chao-Bin Yeh et al. PLoS One
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota
- (2012) Hachung Chung et al. CELL
- Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals
- (2012) Jianjun Liu et al. CURRENT MICROBIOLOGY
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- The human microbiome: at the interface of health and disease
- (2012) Ilseung Cho et al. NATURE REVIEWS GENETICS
- Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
- (2012) D. Compare et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Host-Gut Microbiota Metabolic Interactions
- (2012) J. K. Nicholson et al. SCIENCE
- Characterization of fecal microbial communities in patients with liver cirrhosis
- (2011) Yanfei Chen et al. HEPATOLOGY
- Changes of Fecal Bifidobacterium Species in Adult Patients with Hepatitis B Virus-Induced Chronic Liver Disease
- (2011) Min Xu et al. MICROBIAL ECOLOGY
- Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice
- (2008) Pornprom Yoysungnoen et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now